A breakthrough for Multiple Sclerosis Patients through Stem Cells Transplant

A new breakthrough in the health industry has revealed that there is hope for patients who have multiple sclerosis. The discovery suggests that the future of treating the disease lies in the human stem cells. It also indicated that the transplant of the person’s blood cells contributes largely to the remission of MS. By the use of high dose immune suppressive therapy and autologous hematopoietic cell transplant, the results have indicated no progression of the disease. The study got conducted on people, and after receiving treatment, 69 percent of the candidates reported having no further symptoms, relapse or brain lesions.

With the breakthrough, it is now evident that one single treatment using the stem cells is far much useful than the MS drugs. The trials got conducted on 24 patients of the age 26 to 52. As a result, 70 percent of the patients responded positively to the treatment. It is, therefore, a way to go for patients who are not responsive to conventional drugs.

Dr. Shiva Gopal Vasishta has a major in neurology and psychiatry. He graduated from The Government College in Nagpur. Dr. Shiva Gopal Vasishta brings 40 years of experience to the Kennedy University Hospital. Additionally, he has knowledge and expertise on matters psychiatric disorders, trauma, and epilepsy. On several occasions, an EEG test is performed on these patients to determine the electrical brain activity. Results from this test may indicate the presence or lack of brain tumors, sleeping disorders, epilepsy among others. Patients with these disorders seek help from private doctors and are advised to seek the services of a neurologist, among whom Dr. Shiva Gopal Vasishta is among, for better treatment.

Dr. Shiva Gopal Vasishta has a specialty in Myopathy, a muscle disease that comes as a result of their genetical lineage among other factors. The diagnosis can be conducted using electrocardiography. Today, he lives in residence at Boston Hill Hospital.